BTG completes purchase of Galil Medical

BTG said it had completed its £58.3m purchase of oncology specialist Galil Medical.

Galil specialises in developing devices that kills cancerous tumours by freezing them.

The company's products have indications for the treatment and palliative care of kidney and other cancers in the US, in addition to a number of other uses, including urology, BTG said in May when the deal was announced.

Galil Medical owns, manufactures and sells a portfolio of cryoablation systems and needles. The systems use compressed argon gas to produce extremely low temperatures; as the gas passes through the needle, the tip of the needle is cooled, forming an ice ball, BTG said

The ice ball engulfs the tumour and destroys the tissue. A variety of needle types are available to produce a freeze zone that matches the tumour size and shape, so that adjacent tissue is not damaged, it added.